{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:44:49Z","timestamp":1790646289411,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>\n                                 <jats:sup>99m<\/jats:sup>Tc-pyrophosphate (<jats:sup>99m<\/jats:sup>Tc-PYP) uptake in the skeletal muscles is minimal in patients with transthyretin cardiac amyloidosis (ATTR-CA) when assessed qualitatively and quantitatively. We previously demonstrated moderate- to high-grade <jats:sup>99m<\/jats:sup>Tc-PYP uptake in the subcutaneous abdominal fat of some patients with ATTR-CA and showed that this abnormal finding could reflect the regional amyloid burden of this tissue. We aimed to investigate the frequency of <jats:sup>99m<\/jats:sup>Tc-PYP uptake in skeletal trunk muscles of patients with ATTR-CA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Chest- and abdomen-centered <jats:sup>99m<\/jats:sup>Tc-PYP scintigraphy images were obtained 2 hours after IV injections of the tracer (20 mCi) in 36 patients with ATTR-CA. The frequency of <jats:sup>99m<\/jats:sup>Tc-PYP uptake in the following 11 skeletal trunk muscles was investigated: pectoralis major, deltoid, subscapularis, infraspinatus, trapezius, latissimus dorsi, erector spinae, psoas major, abdominal oblique, rectus abdominis, and the gluteus muscles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ten of the 11 muscles were involved in patients with the highest number of <jats:sup>99m<\/jats:sup>Tc-PYP uptake in the skeletal trunk muscles examined, whereas no muscle was involved in a patient with the least uptake. The muscle with the highest rate of <jats:sup>99m<\/jats:sup>Tc-PYP uptake, observed in 34 of 36 patients (94.4%), was the abdominal oblique. No tracer uptake was observed in the psoas major. The frequency of radiotracer uptake in the remaining examined muscles was between those of abdominal oblique and psoas major muscles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Radiotracer uptake was often detectable in some skeletal trunk muscles of ATTR-CA, although the muscles of patients examined and the skeletal trunk muscles of 1 patient showed heterogeneity in the uptake of <jats:sup>99m<\/jats:sup>Tc-PYP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004397","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:04:15Z","timestamp":1670256255000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["99mTc-Pyrophosphate Scintigraphy Can Image Tracer Uptake in Skeletal Trunk Muscles of Transthyretin Cardiac Amyloidosis"],"prefix":"10.1097","volume":"48","author":[{"given":"Koji","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Hiratsuka","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Sakaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijiro","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroe","family":"Morioka","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Uemura","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Okura","sequence":"additional","affiliation":[{"name":"Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Kono","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Iwamura","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Yamamura","sequence":"additional","affiliation":[{"name":"Clinical Pathology, Yawatahama City General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology, Ehime University Graduate School of Medicine, Ehime"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"bib1-20250621","first-page":"e000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"14","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","year":"2019","journal-title":"JACC Heart Fail"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: a review","volume":"143","year":"2020","journal-title":"Acta Haematol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"bib6-20250621","article-title":"AL-type amyloidosis involving stomach and lungs in 99mTc-DPD bone scan [published online July 14, 2022]","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/RLU.0000000000002877","article-title":"Diffuse hepatosplenic 99mTc-pyrophosphate activity caused by amyloidosis","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/RLU.0000000000003816","article-title":"99mTc-pyrophosphate retention in atelectatic pulmonary tissues of a patient with transthyretin cardiac amyloidosis","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s12350-017-1166-7","article-title":"Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s12350-018-1235-6","article-title":"Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaccas.2021.02.015","article-title":"Extracardiac accumulation of technetium-99m-pyrophosphate in transthyretin cardiac amyloidosis","volume":"3","year":"2021","journal-title":"JACC Case Rep"},{"key":"bib13-20250621","article-title":"Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis [published online December 28, 2021]","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/pin.12902","article-title":"Human amyloidosis, still intractable but becoming curable: the essential role of pathological diagnosis in the selection of type-specific therapeutics","volume":"70","year":"2020","journal-title":"Pathol Int"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s12350-020-02273-3","article-title":"Tc-99m-PYP imaging for cardiac amyloidosis: defining the best protocol before the flood gates burst","volume":"27","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","year":"2017","journal-title":"Eur Heart J"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/acr.20101","article-title":"Amyloid load in fat tissue reflects disease severity and predicts survival in amyloidosis","volume":"62","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2021.10.007","article-title":"Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy","volume":"79","year":"2022","journal-title":"J Cardiol"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1253\/circrep.CR-21-0067","article-title":"Wild-type transthyretin amyloidosis in female patients\u2014consideration of sex differences","volume":"3","year":"2021","journal-title":"Circ Rep"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"bib23-20250621","first-page":"e25444","article-title":"Bradycardia, renal failure, atrioventricular nodal blockade, shock, and hyperkalemia syndrome as a clinical profile leading to the diagnosis of transthyretin amyloidosis: a report of two cases","volume":"14","year":"2022","journal-title":"Cureus"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40119-020-00205-3","article-title":"Estimating the gender distribution of patients with wild-type transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis","volume":"10","year":"2021","journal-title":"Cardiol Ther"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00415-017-8640-7","article-title":"Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan","volume":"265","year":"2018","journal-title":"J Neurol"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","article-title":"Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus","volume":"270","year":"2008","journal-title":"J Neurol Sci"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:02:32Z","timestamp":1750536152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004397","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}